Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
Abstract Survival in multiple myeloma (MM) has developed favorably over the past decades for reasons that have been ascribed to new medications and treatment. However, development of survival over a long period and comparison to other hematopoietic neoplasms (HN) is less well known. Here we used Swe...
Guardado en:
Autores principales: | Kari Hemminki, Asta Försti, Markus Hansson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9dbb698bf1d4a86a408ddf4ec0ea1a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
por: Kari Hemminki, et al.
Publicado: (2021) -
Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden.
por: Kari Hemminki, et al.
Publicado: (2021) -
Familial Ovarian Cancer Clusters with Other Cancers
por: Guoqiao Zheng, et al.
Publicado: (2018) -
Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
por: Kari Hemminki, et al.
Publicado: (2017) -
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib
por: Nooka A, et al.
Publicado: (2013)